Insulin and its Analogs – Options, Formulations, and Efficacy

The WHO has recently added long-acting insulin analogs and biosimilars to its new Essential Medicines List (EML). The recent addition of detemir, glargine, and degludec to WHO's EML is an important step towards health equity. The advances in long-acting and rapid-acting insulin analogs, combined with improved glucose monitoring tools, enable people with diabetes to meet their individual glycemic goals effectively. We bring you an exclusive session on “Insulin and its Analogs – Options, Formulations, and Efficacy” by experts in diabetology. Join us on 8 th October 2024 , 6:00 PM IST onwards!

##Topic 1: Insulin: Options and Formulations – Dr. Lakshmi Hariharan## Session highlights Types of insulin Physiology of insulin secretion Short-acting and long-acting analogs## ##Topic 2: Insulin Analogs: Efficacy, Pros, and Cons – Dr. J. S. Kumar## Session highlights Basal insulin analogs Pre-mix…